Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related Articles
New iPad Amblyopia Treatment is a “Hot Topic” iPad App for Detecting Retinal Disease Receives Second FDA Approval Anonymous One Million Dollar Gift Given to Retina Foundation for AMD Research Recently@Retina Newsletter March 2024 Retina Foundation of the Southwest New Home in Dallas